Suppression for lung metastasis by depletion of collagen I and lysyl oxidase via losartan assisted with paclitaxel-loaded pH-sensitive liposomes in breast cancer

References

• Anscher MS. (2010). Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy. Oncologist 15:350–9
   PubMed Web of Science ®Google Scholar
• Cao H, Zhang Z, Zhao S, et al (2015). Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression. J Control Release 205:162–71
   PubMed Web of Science ®Google Scholar
• Chauhan VP, Martin JD, Liu H, et al (2013). Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat Commun 4:2516
   PubMed Web of Science ®Google Scholar
• Cox TR, Bird D, Baker AM, et al (2013). LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res 73:1721–32
   PubMed Web of Science ®Google Scholar
• Danhier F, Feron O, Preat V. (2010). To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148:135–46
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Lin CC, Mariotto AB, et al (2014). Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64:252–71
   PubMed Web of Science ®Google Scholar
• Diop-Frimpong B, Chauhan VP, Krane S, et al (2011). Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc Natl Acad Sci USA 108:2909–14
   PubMed Web of Science ®Google Scholar
• Eldar-Boock A, Miller K, Sanchis J, et al (2011). Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel. Biomaterials 32:3862–74
   PubMed Web of Science ®Google Scholar
• Erler JT, Bennewith KL, Nicolau M, et al (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440:1222–6
   PubMed Web of Science ®Google Scholar
• Gao ZG, Tian L, Hu J, et al (2011). Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles. J Control Release 152:84–9
   PubMed Web of Science ®Google Scholar
• Gilkes DM, Chaturvedi P, Bajpai S, et al (2013). Collagen prolyl hydroxylases are essential for breast cancer metastasis. Cancer Res 73:3285–96
   PubMed Web of Science ®Google Scholar
• Gilkes DM, Semenza GL, Wirtz D. (2014). Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Cancer 14:430–9
   PubMed Web of Science ®Google Scholar
• Gupta GP, Massague J. (2006). Cancer metastasis: building a framework. Cell 127:679–95
   PubMed Web of Science ®Google Scholar
• Guzman A, Ziperstein MJ, Kaufman LJ. (2014). The effect of fibrillar matrix architecture on tumor cell invasion of physically challenging environments. Biomaterials 35:6954–63
   PubMed Web of Science ®Google Scholar
• Hozumi K, Fujimori C, Katagiri F, et al (2015). Suppression of cell adhesion through specific integrin crosstalk on mixed peptide-polysaccharide matrices. Biomaterials 37:73–81
   PubMed Web of Science ®Google Scholar
• Kalluri R, Han Y. (2008). Targeting TGF-beta and the extracellular matrix in Marfan’s syndrome. Dev Cell 15:1–2
   PubMed Web of Science ®Google Scholar
• Kleinman HK, Martin GR. (2005). Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15:378–86
   PubMed Web of Science ®Google Scholar
• Levental KR, Yu H, Kass L, et al (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139:891–906
   PubMed Web of Science ®Google Scholar
• Liu Y, Ran R, Chen J, et al (2014). Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting. Biomaterials 35:4835–47
   PubMed Web of Science ®Google Scholar
• Lu J, Liu C, Wang P, et al (2015). The self-assembling camptothecin-tocopherol prodrug: an effective approach for formulating camptothecin. Biomaterials 62:176–87
   PubMed Web of Science ®Google Scholar
• Mei L, Liu Y, Zhang Q, et al (2014). Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin. J Control Release 196:324–31
   PubMed Web of Science ®Google Scholar
• Mo R, Sun Q, Li N, et al (2013). Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids. Biomaterials 34:2773–86
   PubMed Web of Science ®Google Scholar
• Nguyen-Ngoc KV, Cheung KJ, Brenot A, et al (2012). ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. Proc Natl Acad Sci USA 109:E2595–604
   PubMed Web of Science ®Google Scholar
• Pang Y, Gara SK, Achyut BR, et al (2013). TGF-β signaling in myeloid cells is required for tumor metastasis. Cancer Discov 3:936–51
   PubMed Web of Science ®Google Scholar
• Pickup MW, Laklai H, Acerbi I, et al (2013). Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas. Cancer Res 73:5336–46
   PubMed Web of Science ®Google Scholar
• Ryu S, McDonnell K, Choi H, et al (2013). Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration. Cancer Cell 23:63–76
   PubMed Web of Science ®Google Scholar
• Sawant RM, Hurley JP, Salmaso S, et al (2006). “SMART” drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem 17:943–9
   PubMed Web of Science ®Google Scholar
• Shao K, Ding N, Huang S, et al (2014). Smart nanodevice combined tumor-specific vector with cellular microenvironment-triggered property for highly effective antiglioma therapy. ACS Nano 8:1191–203
   PubMed Web of Science ®Google Scholar
• Shintani Y, Hollingsworth MA, Wheelock MJ, et al (2006). Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression. Cancer Res 66:11745–53
   PubMed Web of Science ®Google Scholar
• Steeg PS. (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12:895–904
   PubMed Web of Science ®Google Scholar
• Tang J, Fu H, Kuang Q, et al (2014). Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery. J Drug Target 22:313–26
   PubMed Web of Science ®Google Scholar
• Valastyan S, Weinberg RA. (2011). Tumor metastasis: molecular insights and evolving paradigms. Cell 147:275–92
   PubMed Web of Science ®Google Scholar
• Wan L, Pantel K, Kang Y. (2013). Tumor metastasis: moving new biological insights into the clinic. Nat Med 19:1450–64
   PubMed Web of Science ®Google Scholar
• Xu P, Yu H, Zhang Z, et al (2014). Hydrogen-bonded and reduction-responsive micelles loading atorvastatin for therapy of breast cancer metastasis. Biomaterials 35:7574–87
   PubMed Web of Science ®Google Scholar
• Yang Y, Pan D, Luo K, et al (2013). Biodegradable and amphiphilic block copolymer-doxorubicin conjugate as polymeric nanoscale drug delivery vehicle for breast cancer therapy. Biomaterials 34:8430–43
   PubMed Web of Science ®Google Scholar
• Yin Y, Wu X, Yang Z, et al (2013). The potential efficacy of R8-modified paclitaxel-loaded liposomes on pulmonary arterial hypertension. Pharm Res 30:2050–62
   PubMed Web of Science ®Google Scholar
• Zhang J, Li X, Huang L. (2014). Non-viral nanocarriers for siRNA delivery in breast cancer. J Control Release 190:440–50
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang Y, Yang Y, et al (2015a). High tumor penetration of paclitaxel loaded pH sensitive cleavable liposomes by depletion of tumor collagen I in breast cancer. ACS Appl Mater Interfaces 7:9691–701
   PubMed Web of Science ®Google Scholar
• Zhang Q, Tang J, Fu L, et al (2013). A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. Biomaterials 34:7980–93
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ran R, Zhang L, et al (2015b). Simultaneous delivery of therapeutic antagomirs with paclitaxel for the management of metastatic tumors by a pH-responsive anti-microbial peptide-mediated liposomal delivery system. J. Controlled Release 197:208–18
   PubMed Web of Science ®Google Scholar
• Zong T, Mei L, Gao H, et al (2014). Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals. Mol Pharm 11:2346–57
   PubMed Web of Science ®Google Scholar